Browsing William Harvey Research Institute by Title

<i>De motu cordis</i>: the future of regenerative medicine

Mathur, A (2019)

<i>EAP1</i> Mutations Cause an Impaired Transcriptional Activity on GnRH Promoter That Leads to Self-Limited Delayed Puberty

Mancini, A; Howard, SR; Cabrera, CP; Barnes, MR; Heger, S; Guasti, L; Ojeda, S; Dunkel, L (2018)

Iatrogenic cardiac perforation due to pacemaker and defibrillator leads: a contemporary multicentre experience

Waddingham, PH; Elliott, J; Bates, A; Bilham, J; Muthumala, A; Honarbakhsh, S; Ullah, W; Hunter, RJ; Lambiase, PD; Lane, RE (2022)

Iatrogenic catheter-induced ostial coronary artery dissections: Prevalence, management, and mortality from a cohort of 55,968 patients over 10 years

Ramasamy, A; Bajaj, R; Jones, DA; Amersey, R; Mathur, A; Baumbach, A; Bourantas, CV; O'Mahony, C (2021)

Ichthyosis linked to sphingosine 1-phosphate lyase insufficiency is due to aberrant sphingolipid and calcium regulation

Smith, CJ; Williams, JL; Hall, C; Casas, J; Caley, MP; O'Toole, EA; Prasad, R; Metherell, LA (2023)

ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis

Alves, GF; Stoppa, I; Aimaretti, E; Monge, C; Mastrocola, R; Porchietto, E; Einaudi, G; Collotta, D; Bertocchi, I; Boggio, E (2022)

ID:16364 Effectiveness of High Dose Spinal Cord Stimulation for Nonsurgical Intractable Lumbar Radiculopathy - HIDENS Study

Poply, K; Sharma, S; Nikolic, S; Ahmad, A; Lascelles, J; Elyas, A; Ganeshan, B; Ellamushi, H; Mehta, V (Elsevier, 2022-07)

Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation

Colas, RA; Dalli, J; Chiang, N; Vlasakov, I; Sanger, JM; Riley, IR; Serhan, CN (2016-12-01)

Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity

David, A; Miraki-Moud, F; Shaw, NJ; Savage, MO; Clark, AJL; Metherell, LA (2010-01)

Identification and characterisation of the high-risk surgical population in the United Kingdom

Pearse, RM; Harrison, DA; James, P; Watson, D; Hinds, C; Rhodes, A; Grounds, RM; Bennett, ED (2006)

Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology

Dalli, J; Serhan, CN (2019)

Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study.

Hoste, E; Bihorac, A; Al-Khafaji, A; Ortega, LM; Ostermann, M; Haase, M; Zacharowski, K; Wunderink, R; Heung, M; Lissauer, M (2020-02-06)

PURPOSE: The aim of the RUBY study was to evaluate novel candidate biomarkers to enable prediction of persistence of renal dysfunction as well as further understand potential mechanisms of kidney tissue damage and repair ...

Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling.

Subramanian, M; Thorp, E; Tabas, I (2015-01-16)

RATIONALE: Granulocyte macrophage colony-stimulating factor (GM-CSF, Csf2) is a growth factor for myeloid-lineage cells that has been implicated in the pathogenesis of atherosclerosis and other chronic inflammatory diseases. ...

Identification of a Novel Recycling Sequence in the C-tail of FPR2/ALX Receptor ASSOCIATION WITH CELL PROTECTION FROM APOPTOSIS

Thompson, D; McArthur, S; Hislop, JN; Flower, RJ; Perretti, M (2014-12-26)

Identification of a novel specific small-molecule melanocortin-2-receptor antagonist

Forfar, R; Hussain, M; Khurana, P; Cook, J; Lewis, S; Popat, D; Jackson, D; McIver, E; Jerman, J; Taylor, D (2022)

Identification of a rare coding variant in complement 3 associated with age-related macular degeneration

Zhan, X; Larson, DE; Wang, C; Koboldt, DC; Sergeev, YV; Fulton, RS; Fulton, LL; Fronick, CC; Branham, KE; Bragg-Gresham, J (2013-09-15)

Identification of an activated neutrophil phenotype in polymyalgia rheumatica during steroid treatment: a potential involvement of immune cell cross-talk.

Nadkarni, S; Lashin, H; Hollywood, J; Dasgupta, B; Mason, JC; Perretti, M (2019-04-15)

We have reported the existence of a distinct neutrophil phenotype in giant cell arteritis (GCA) patients arising at week 24 of steroid treatment. In the present study, we investigated whether longitudinal analysis of ...

Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth.

Ferrari, L; Scuvera, G; Tucci, A; Bianchessi, D; Rusconi, F; Menni, F; Battaglioli, E; Milani, D; Riva, P (2017-10)

Neurofibromatosis type I (NF1) microdeletion syndrome, which is present in 4-11% of NF1 patients, is associated with a severe phenotype as it is caused by the deletion of NF1 and other genes in the 17q11.2 region. The ...

Identification of AnnexinA1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes.

PURVIS, G; Collino, M; Loiola, R-A; Baragetti, A; Chiazza, F; Brovelli, M; Sheikh, MH; Collotta, D; Cento, A; Mastrocola, R

Identification of AnnexinA1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes.

SOLITO, E; PURVIS, GSD; Collino, M; Azevedo Loiola, R; Baragetti, A; Chiazza, F; Brovelli, M; Collotta, D; Sheikh, M; Cento, A (Frontiers Media, 2019-03-27)

Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important role in the pathophysiology of diseases associated with chronic inflammation. We demonstrate that patients with type-2 ...